As the federal government closes its probe into our first Varroa mite outbreak without finding its source, the honey bee ...
Celltrion launches 300 mg strength of Omlyclo in Europe to treat chronic spontaneous urticaria and allergic asthma: Incheon, South Korea Wednesday, August 26, 2026, 15:00 Hrs [IST ...
Celltrion launched a 300mg version of its allergy drug Omlyclo in Germany, Britain, France and other major European markets, ...
Celltrion has launched the 300mg formulation of Omriclo (omalizumab), its treatment for chronic spontaneous urticaria and ...
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced the ...
Johnson & Johnson (NYSE: JNJ) today announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY® ...
Celltrion expands its Omlyclo® portfolio in Europe by launching the 300 mg strength in PFS and AI presentations.
A daily moisturizing routine can help rehydrate your skin and, in turn, soothe your itchiness. Opt for a fragrance-free ...
Doctors in Sydney, Australia, discovered Ayla Cullen had a grapefruit-sized kidney tumour after her mum spotted her mood ...
Nurix secures a transformative Roche partnership, gaining $700M upfront, 50% U.S. profit share, and 60% Roche-funded global ...
Salish Lodge & Spa is already abuzz with energy for its annual Honey Month celebration. Starting Sept. 1, the Snoqualmie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results